Moxilubant

DB19718ExperimentalSmall molecule

Moxilubant is a small molecule drug. The usage of the INN stem '-lubant' in the name indicates that Moxilubant is a leukotriene B4 receptor antagonist. Moxilubant has a monoisotopic molecular...

Formula / weight: C₂₆H₃₇N₃O₄ · 455.599 g/mol (avg)

Resolves to

Compound

UNII2F3QKD3W17CAS146978-48-5ChEMBLCHEMBL89326

Structure

InChIKeyVAYJLOGCWOXMAS-UHFFFAOYSA-NSMILESCOC1=CC(=CC=C1OCCCCCOC1=CC=C(C=C1)C(N)=N)C(=O)N(C(C)C)C(C)C

Which companies are running trials of Moxilubant, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account